Oxfordbio
Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Oxfordbio Information
Geographic Data
Address: Robert Robinson Avenue
City: Oxford
State: england
Zip: OX4 4GA
Country: GB
Financial Info
Stage:
undisclosed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Oxford Cancer Biomarkers is developing and commercializing a suite of colorectal cancer biomarker tests to improve the current treatment pathway. Oxford Cancer Biomarkers is closely affiliated with Institute of Cancer Medicine at Oxford University, where its founders lead translational cancer science research groups. Oxford Cancer Biomarkers has also partnered with pharmaceutical companies to use its discovery platforms CancerNav® and ToxNavTM to develop companion diagnostic tests for pipeline drugs.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2019 | Funding Round | 1 | - |
Kwang Dong Pharmaceutical Kwang Dong Pharmaceutical |
12/2015 | Venture Round | 2 | - |
Esperante Ventures Longwall Venture Partners Esperante Ventures Longwall Venture Partners |
6/2019 | Funding Round | 1 | - |
Kwang Dong Pharmaceutical Kwang Dong Pharmaceutical |
12/2015 | Venture Round | 2 | - |
Esperante Ventures Longwall Venture Partners Esperante Ventures Longwall Venture Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
